Authors:
PAWLOTSKY JM
LONJON I
HEZODE C
RAYNARD B
DARTHUY F
REMIRE J
SOUSSY CJ
DHUMEAUX D
Citation: Jm. Pawlotsky et al., WHAT STRATEGY SHOULD BE USED FOR DIAGNOSIS OF HEPATITIS-C VIRUS-INFECTION IN CLINICAL LABORATORIES, Hepatology, 27(6), 1998, pp. 1700-1702
Authors:
PAWLOTSKY JM
BASTIE A
HEZODE C
LONJON I
DARTHUY F
REMIRE J
SOUSSY CJ
Citation: Jm. Pawlotsky et al., QUANTIFICATION OF HEPATITIS-B VIRUS-DNA IN CLINICAL-SAMPLES - TARGET VERSUS SIGNAL AMPLIFICATION, Hepatology, 26(4), 1997, pp. 754-754
Authors:
HEZODE C
CAZENEUVE C
COUE O
LONJON I
BASTIE A
DUVOUX C
PAWLOTSKY JM
ZAFRANI ES
AMSELEM S
DHUMEAUX D
Citation: C. Hezode et al., LIVER IRON OVERLOAD IN PATIENTS WITH CHRONIC ACTIVE HEPATITIS-C - PREVALENCE, ROLE OF THE HEMOCHROMATOSIS GENE AND RELATION WITH HEPATIC HISTOLOGICAL LESIONS, Hepatology, 26(4), 1997, pp. 1129-1129
Authors:
PAWLOTSKY JM
BASTIE A
LONJON I
REMIRE J
DARTHUY F
SOUSSY CJ
DHUMEAUX D
Citation: Jm. Pawlotsky et al., WHAT TECHNIQUE SHOULD BE USED FOR ROUTINE DETECTION AND QUANTIFICATION OF HBV DNA IN CLINICAL-SAMPLES, Journal of virological methods, 65(2), 1997, pp. 245-253
Authors:
LONJON I
BEAUGERIE L
DESCHAMPS A
BARTHET C
CARBONNEL F
NGO Y
COSNES J
ABUAF N
GENDRE JP
Citation: I. Lonjon et al., PREVALENCE OF ANTICARDIOLIPIN ANTIBODIES IN CROHNS-DISEASE, Gastroenterologie clinique et biologique, 20(8-9), 1996, pp. 633-637
Authors:
PAWLOTSKY JM
GANNECARRIE N
FRAINAIS PO
LONJON I
BASTIE A
DARTHUY F
REMIRE J
DUVAL J
BEAUGRAND M
DHUMEAUX D
Citation: Jm. Pawlotsky et al., EVOLUTION OF THE HEPATITIS-C VIRUS ENDEMICS IN INTRAVENOUS DRUG-ABUSERS - A GENOTYPING STUDY, Hepatology, 24(4), 1996, pp. 104-104
Authors:
POYNARD T
LONJON I
MATHURIN P
ABELLA A
MUSSET D
BEDOSSA P
AUBERT A
NAVEAU S
CHAPUT JC
Citation: T. Poynard et al., PREVALENCE OF CHOLELITHIASIS ACCORDING TO ALCOHOLIC LIVER-DISEASE - APOSSIBLE ROLE OF APOLIPOPROTEINS AI AND AII, Alcoholism, clinical and experimental research, 19(1), 1995, pp. 75-80